Change search criteria ↓

Search results

37 projects found matching your search criteria:

  1. 1. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra…

    Principal investigator: dr hab. Zofia Maria Rogóż

    Instytut Farmakologii PAN

    Call: OPUS 12, Panel: NZ7

  2. 2. Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

    Principal investigator: Katarzyna Karolina Kamińska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 5, Panel: NZ7

  3. 3. Development of bioanalytical procedures to assess the effects of antidepressants on the neurovascular unit (NVU), taking…

    Principal investigator: dr Agnieszka Żuchowska

    Politechnika Warszawska

    Call: SONATA BIS 15, Panel: ST4

  4. 4. Zinc Deficiency: An essential Variable for the Induction od Resistance to Antidepressants

    Principal investigator: dr Anna Maria Rafało-Ulińska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 13, Panel: NZ5

  5. 5. Role of oxidative stress and ceramide in the pathogenesis of depression and in the mechanizm of action of antidepressant…

    Principal investigator: Justyna Józefa Brodowicz

    Instytut Farmakologii PAN

    Call: PRELUDIUM 12, Panel: NZ5

  6. 6. The role of inflammation, oxidative and nitrosative stress, tryptophan catabolites pathway and DNA base excision repair …

    Principal investigator: dr hab. Tomasz Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 10, Panel: NZ7

  7. 7. Functional dissection of three alpha(1)-adrenergic receptor subtypes in the effects of antidepressant drugs: exploitatio…

    Principal investigator: prof. Irena Maria Nalepa

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  8. 8. Molecular mechanism of action of antidepressant drugs in the in vitro model of contact allergy in the human cell line Ha…

    Principal investigator: Katarzyna Curzytek

    Instytut Farmakologii PAN

    Call: PRELUDIUM 7, Panel: NZ6

  9. 9. Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment: study on the novel genet…

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ7

  10. 10. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

    Call: OPUS 5, Panel: NZ7

  11. 11. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d…

    Principal investigator: dr Maciej Sławomir Kuśmider

    Instytut Farmakologii PAN

    Call: OPUS 4, Panel: NZ4

  12. 12. The role of CRH-BP protein in the regulation of the hypothalamic-pituitary-adrenal axis after antidepressant drugs treat…

    Principal investigator: dr Joanna Solich

    Instytut Farmakologii PAN

    Call: OPUS 3, Panel: NZ4

  13. 13. Role of the endocannabionoid system in the pathogenesis of depression and in the mechanism of action of antidepressant d…

    Principal investigator: prof. Małgorzata Maria Filip

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 3, Panel: NZ7

  14. 14. The role of GPR39 receptor in the mechanism of antidepressant action

    Principal investigator: dr Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 2, Panel: NZ7

  15. 15. Metabolic stability and inhibition of P450 enzymes in combination with chemometric techniques as a tool for selection of…

    Principal investigator: prof. Tomasz Bączek

    Gdański Uniwersytet Medyczny, Wydział Farmcautyczny z Oddziałem Medycyny Laboratoryjnej

    Call: OPUS 2, Panel: NZ1

  16. 16. Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte…

    Principal investigator: Dominika Kunachowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: PRELUDIUM 23, Panel: NZ5

  17. 17. The influence of microplastics on the toxicity and fate of selected antidepressants

    Principal investigator: prof. Grzegorz Leszek Nałęcz-Jawecki

    Warszawski Uniwersytet Medyczny

    Call: OPUS 18, Panel: NZ8

  18. 18. Pharmacokinetic and pharmacodynamics modeling of antidepressants in a mechanistic approach for efficient therapy.

    Principal investigator: prof. Filip Rybakowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 29, Panel: NZ7

  19. 19. Dual Se-containing 5-HT1A and 5-HT7 biased agonists activating sigma-1 receptor as a hope of finding fast-acting antidep…

    Principal investigator: prof. Karolina Anna Pytka

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ7

  20. 20. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ7

  21. 21. Translational and interdisciplinary investigation of phenotypes of reinforcement sensitivity as predictors of the respon…

    Principal investigator: dr hab. Rafał Ryguła

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: HS6

  22. 22. Modeling of quantitative structure-metabolic stability relationships as a tool to improve design of potential novel anti…

    Principal investigator: prof. Tomasz Bączek

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

    Call: OPUS 12, Panel: NZ7

  23. 23. Role of the NLRP3 inflammasome in the mechanisms of action of antidepressant drugs - study in an animal model of depress…

    Principal investigator: dr Ewa Izabela Trojan

    Instytut Farmakologii PAN

    Call: PRELUDIUM 9, Panel: NZ7

  24. 24. Selected antidepressants toxicity assessment based on in vitro studies of rat spermatocytes and mouse cell lines.

    Principal investigator: Przemysław Paweł Sołek

    Uniwersytet Rzeszowski, Wydział Biotechnologii

    Call: PRELUDIUM 8, Panel: NZ7

  25. 25. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br…

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii PAN

    Call: SONATA 16, Panel: NZ7

  26. 26. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud…

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

    Call: OPUS 28, Panel: NZ7

  27. 27. The effect of the metabotropic glutamatergic receptor ligands on potentiating the antidepressant-like actvity of scopola…

    Principal investigator: Karolina Sylwia Podkowa

    Instytut Farmakologii PAN

    Call: PRELUDIUM 10, Panel: NZ7

  28. 28. The application of a modern chromatographic platform with biodetection: HPLC-DAD/MAO A/ESI-TOF-MS in the antidepressant …

    Principal investigator: dr hab. Wirginia Anna Kukuła-Koch

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: SONATA 9, Panel: NZ7

  29. 29. Research of mechanisms of antidepressant action of group II and III mGlu receptor ligands and their role in inducing rap…

    Principal investigator: dr hab. Agnieszka Pałucha-Poniewiera

    Instytut Farmakologii PAN

    Call: OPUS 7, Panel: NZ7

  30. 30. The role of the immune checkpoints in the pathomechanism of depressive disorders.

    Principal investigator: prof. Marta Wanda Kubera

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ6

  31. 31. Novel pharmacological strategies for the treatment of depression

    Principal investigator: dr hab. Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 16, Panel: NZ7

  32. 32. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 13, Panel: NZ7

  33. 33. The importance of interaction between NMDA and AMPA receptors and scaffolding proteins in the excitatory synaptic in the…

    Principal investigator: dr hab. Magdalena Jolanta Sowa-Kućma

    Uniwersytet Rzeszowski, Kolegium Nauk Medycznych

    Call: OPUS 11, Panel: NZ7

  34. 34. Investigation of the effects and mechanisms of action of Deep Brain Stimulation in two animal models of treatment-resist…

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ7

  35. 35. Synthesis of pyridopyrimidine derivatives, dual affinity ligands for 5-HT1AR and SERT.

    Principal investigator: prof. Franciszek Herold

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

    Call: OPUS 6, Panel: NZ7

  36. 36. Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmac…

    Principal investigator: dr Magdalena Jolanta Sowa-Kućma

    Instytut Farmakologii PAN

    Call: SONATA 5, Panel: NZ7

  37. 37. Evaluation of the role of subpopulations of T lymphocytes (Treg: CD4+CD25+, CD4+CD25- i Teff: Th2) in depression using p…

    Principal investigator: dr Sylwia Kędracka-Krok

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: OPUS 3, Panel: NZ4

Graphic design and implementation: Jakub Piotrowski